Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.20.2
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
Series D Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2018 $ 5 $ 26,118 $ 175,924,587 $ (159,856,481) $ 16,094,229
Balance, shares at Dec. 31, 2018 5,141 26,118,075        
Stock-based compensation $ 52 118,684 118,736
Stock-based compensation, shares 51,724        
Restricted stock issued in satisfaction of accrued issuable equity $ 57 199,831 199,888
Restricted stock issued in satisfaction of accrued issuable equity, shares 56,948        
Common stock issued upon conversion of Series D convertible preferred stock $ 5 (5)
Common stock issued upon conversion of Series D convertible preferred stock, shares (16) 5,128        
Return and retirement of common stock $ (8) 8
Return and retirement of common stock, shares (8,066)        
Other comprehensive income loss 100,686 100,686
Net loss (1,893,627) (1,893,627)
Balance at Mar. 31, 2019 $ 5 $ 26,224 176,243,105 100,686 (161,750,108) 14,619,912
Balance, shares at Mar. 31, 2019 5,125 26,223,809        
Balance at Dec. 31, 2018 $ 5 $ 26,118 175,924,587 (159,856,481) 16,094,229
Balance, shares at Dec. 31, 2018 5,141 26,118,075        
Restricted stock issued in satisfaction of accrued issuable equity           252,358
Net loss           (6,753,836)
Balance at Sep. 30, 2019 $ 5 $ 26,261 176,540,422 108,169 (166,610,317) 10,064,540
Balance, shares at Sep. 30, 2019 5,125 26,261,434        
Balance at Mar. 31, 2019 $ 5 $ 26,224 176,243,105 100,686 (161,750,108) 14,619,912
Balance, shares at Mar. 31, 2019 5,125 26,223,809        
Stock-based compensation   185,632 185,632
Stock-based compensation, shares        
Restricted stock issued in satisfaction of accrued issuable equity $ 13 40,142 40,155
Restricted stock issued in satisfaction of accrued issuable equity, shares 12,995        
Other comprehensive income loss 40,321 40,321
Net loss (2,237,220) (2,237,220)
Balance at Jun. 30, 2019 $ 5 $ 26,237 176,468,879 141,007 (163,987,328) 12,648,800
Balance, shares at Jun. 30, 2019 5,125 26,236,804        
Stock-based compensation $ 20 59,232 59,252
Stock-based compensation, shares 20,000        
Restricted stock issued in satisfaction of accrued issuable equity $ 4 12,311 12,315
Restricted stock issued in satisfaction of accrued issuable equity, shares 4,630        
Other comprehensive income loss (32,838) (32,838)
Net loss (2,622,989) (2,622,989)
Balance at Sep. 30, 2019 $ 5 $ 26,261 176,540,422 108,169 (166,610,317) 10,064,540
Balance, shares at Sep. 30, 2019 5,125 26,261,434        
Balance at Dec. 31, 2019 $ 5 $ 26,323 176,729,926 183,173 (169,504,981) 7,434,446
Balance, shares at Dec. 31, 2019 5,125 26,322,583        
Stock-based compensation 276,675 276,675
Stock-based compensation, shares        
Common stock issued upon conversion of Series D convertible preferred stock $ (5) $ 1,642 (1,637)
Common stock issued upon conversion of Series D convertible preferred stock, shares (5,125) 1,642,628        
Other comprehensive income loss (181,468) (181,468)
Net loss (2,961,100) (2,961,100)
Balance at Mar. 31, 2020 $ 27,965 177,004,964 1,705 (172,466,081) 4,568,553
Balance, shares at Mar. 31, 2020 27,965,211        
Balance at Dec. 31, 2019 $ 5 $ 26,323 176,729,926 183,173 (169,504,981) 7,434,446
Balance, shares at Dec. 31, 2019 5,125 26,322,583        
Restricted stock issued in satisfaction of accrued issuable equity          
Net loss           (9,904,962)
Balance at Sep. 30, 2020 $ 31,747 195,614,476 (179,409,943) 16,236,280
Balance, shares at Sep. 30, 2020 31,747,100        
Balance at Mar. 31, 2020 $ 27,965 177,004,964 1,705 (172,466,081) 4,568,553
Balance, shares at Mar. 31, 2020 27,965,211        
Stock-based compensation $ 58 72,070 72,128
Stock-based compensation, shares 57,542        
Other comprehensive income loss 63,052 63,052
Common stock issued in public offering [1] $ 1,661 3,755,948 3,757,609
Common stock issued in public offering, shares [1] 1,660,884        
Net loss (3,029,513) (3,209,513)
Balance at Jun. 30, 2020 $ 29,684 180,832,982 64,757 (175,495,594) 5,431,829
Balance, shares at Jun. 30, 2020 29,683,637        
Stock-based compensation $ 6 $ 164,629 $ 164,635
Stock-based compensation, shares 6,847        
Common stock issued upon conversion of Series D convertible preferred stock, shares
Other comprehensive income loss $ (64,757) $ (64,757)
Common stock issued in public offering [2] $ 1,861 14,456,744 14,458,605
Common stock issued in public offering, shares [2] 1,861,087        
Common stock issued upon exercise of warrants $ 196 144,117 144,313
Common stock issued upon exercise of warrants, shares 195,529        
Options issued in satisfaction of accrued issuable equity 16,004 16,004
Net loss (3,914,349) (3,914,349)
Balance at Sep. 30, 2020 $ 31,747 $ 195,614,476 $ (179,409,943) $ 16,236,280
Balance, shares at Sep. 30, 2020 31,747,100        
[1] Includes gross proceeds of $3,998,618, less issuance costs of $241,009.
[2] Includes gross proceeds of $14,954,705, less issuance costs of $496,100. As of September 30, 2020, $419,494 of net proceeds had not been received by the Company and was included as a subscription receivable.